We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04445194
Recruitment Status : Unknown
Verified December 2020 by Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd..
Recruitment status was:  Active, not recruiting
First Posted : June 24, 2020
Last Update Posted : December 3, 2020
The Second Affiliated Hospital of Chongqing Medical University
Beijing Chao Yang Hospital
Information provided by (Responsible Party):
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.